These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8798406)

  • 21. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside.
    Husain SR; Puri RK
    J Neurooncol; 2003 Oct; 65(1):37-48. PubMed ID: 14649884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Site-specific conjugation to interleukin 4 containing mutated cysteine residues produces interleukin 4-toxin conjugates with improved binding and activity.
    Kreitman RJ; Puri RK; Leland P; Lee B; Pastan I
    Biochemistry; 1994 Sep; 33(38):11637-44. PubMed ID: 7918378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel anti-brain tumor cytotoxins specific for cancer cells.
    Debinski W; Gibo DM; Obiri NI; Kealiher A; Puri RK
    Nat Biotechnol; 1998 May; 16(5):449-53. PubMed ID: 9592393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts.
    Kawakami K; Husain SR; Bright RK; Puri RK
    Cancer Gene Ther; 2001 Nov; 8(11):861-8. PubMed ID: 11773976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of target genes induced by IL-13 cytotoxin in human glioblastoma cells.
    Han J; Yang L; Puri RK
    J Neurooncol; 2005 Mar; 72(1):35-46. PubMed ID: 15803373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy.
    Shimamura T; Husain SR; Puri RK
    Neurosurg Focus; 2006 Apr; 20(4):E11. PubMed ID: 16709016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An improved circularly permuted interleukin 4-toxin is highly cytotoxic to human renal cell carcinoma cells. Introduction of gamma c chain in RCC cells does not improve sensitivity.
    Puri RK; Leland P; Obiri NI; Husain SR; Mule J; Pastan I; Kreitman RJ
    Cell Immunol; 1996 Jul; 171(1):80-6. PubMed ID: 8660841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Ralpha2 as a decoy receptor for IL13.
    Bernard J; Treton D; Vermot-Desroches C; Boden C; Horellou P; Angevin E; Galanaud P; Wijdenes J; Richard Y
    Lab Invest; 2001 Sep; 81(9):1223-31. PubMed ID: 11555670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A chimeric protein comprised of IL-4 and Pseudomonas exotoxin is cytotoxic for activated human lymphocytes.
    Puri RK; Mehrotra PT; Leland P; Kreitman RJ; Siegel JP; Pastan I
    J Immunol; 1994 Apr; 152(7):3693-700. PubMed ID: 8144944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
    Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
    J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma.
    Puri RK; Hoon DS; Leland P; Snoy P; Rand RW; Pastan I; Kreitman RJ
    Cancer Res; 1996 Dec; 56(24):5631-7. PubMed ID: 8971168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor.
    Obiri NI; Leland P; Murata T; Debinski W; Puri RK
    J Immunol; 1997 Jan; 158(2):756-64. PubMed ID: 8992992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. hIL-13-PE38QQR. NeoPharm.
    Barth S
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1309-13. PubMed ID: 11717820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen.
    Debinski W; Gibo DM
    Mol Med; 2000 May; 6(5):440-9. PubMed ID: 10952023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular targeting of malignant gliomas with novel multiply-mutated interleukin 13-based cytotoxins.
    Nash KT; Thompson JP; Debinski W
    Crit Rev Oncol Hematol; 2001; 39(1-2):87-98. PubMed ID: 11418305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastoma.
    Puri RK
    Toxicol Pathol; 1999; 27(1):53-7. PubMed ID: 10367674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined effects of radiation and interleukin-13 receptor-targeted cytotoxin on glioblastoma cell lines.
    Kawakami K; Kawakami M; Liu Q; Puri RK
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):230-7. PubMed ID: 16111594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.
    Malabarba MG; Rui H; Deutsch HH; Chung J; Kalthoff FS; Farrar WL; Kirken RA
    Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):865-72. PubMed ID: 8920992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.
    Mintz A; Gibo DM; Slagle-Webb B; Christensen ND; Debinski W
    Neoplasia; 2002; 4(5):388-99. PubMed ID: 12192597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.
    Rolling C; Treton D; Pellegrini S; Galanaud P; Richard Y
    FEBS Lett; 1996 Sep; 393(1):53-6. PubMed ID: 8804422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.